Pioglitazone enhances insulin sensitivity in patients with Type 2 diabetes mellitus.

被引：0
|
作者：
Pavo, I
Herz, M
Tan, M
Shestakova, MV
Smirnova, OM
Jermendy, G
Kerenyi, Z
Widel, MH
Schluchter, BJ
Johns, D
机构：
[1] Lilly Res Labs, Area Med Ctr Vienna, Vienna, Austria
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Endocrinol Res Ctr, Moscow, Russia
[4] Bajesy Zsilinszky Hosp, Budapest, Hungary
[5] St Imre Hosp, Budapest, Hungary
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
779
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [1] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    DIABETOLOGIA, 2002, 45 : A251 - A252
  • [2] Pioglitazone insulin sensitivity and type 2 diabetes mellitus: recent data
    Monnier, L
    Sauvanet, JP
    ANNALES D ENDOCRINOLOGIE, 2004, 65 (02) : 136 - 148
  • [3] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    DIABETES, 2002, 51 : A102 - A102
  • [4] Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
    Roden, M
    Laakso, M
    Johns, D
    Widel, M
    Urquhart, R
    Richardson, C
    Mariz, S
    Tan, MH
    DIABETIC MEDICINE, 2005, 22 (08) : 1101 - 1106
  • [5] Dose-response effect of pioglitazone on insulin sensitivity in type 2 diabetes mellitus
    Miyazaki, Y
    Bawa, N
    Defronzo, RA
    DIABETES, 2001, 50 : A126 - A126
  • [6] Improved insulin secretion and sensitivity by Glimepiride in new onset Type 2 Diabetes Mellitus.
    Kabadi, UM
    Kabadi, MU
    DIABETOLOGIA, 2001, 44 : A216 - A216
  • [7] The Mechanisms by Which Pioglitazone Improves Insulin Sensitivity and Increases Body Weight in Patients with Type 2 Diabetes Mellitus
    Hirai, Hiroyuki
    Satoh, Hiroaki
    Kudoh, Akihiro
    Hasegawa, Koji
    Yamazaki, Satoru
    Sugaya, Yoshiyuki
    Fujiwara, Makoto
    Honma, Miyuki
    Nakajima, Shinichi
    Midorikawa, Sanae
    Watanabe, Tsuyoshi
    DIABETES, 2009, 58 : A360 - A360
  • [8] Insulin analogues: new therapies for type 2 diabetes mellitus.
    Bethel M.A.
    Feinglos M.N.
    Current Diabetes Reports, 2002, 2 (5) : 403 - 408
  • [9] Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with type 2 diabetes mellitus.
    Sidharta, Patricia N.
    Rave, Klaus
    Heise, Tim
    Chiossi, Eleonora
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1083 - 1083
  • [10] Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM)
    Miyazaki, Y
    Mahankali, A
    Matsuda, M
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, RA
    DIABETES, 2000, 49 : A299 - A299
12345